Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cathepsin C (CTSC), also known as dipeptidyl peptidase I (DPP-I), is a lysosomal exo-cysteine protease that plays a central role in activating serine proteases critical for immune cell function, particularly those involved in inflammation. It catalyzes the excision of dipeptides from the N-terminus of proteins and peptides and is implicated in various diseases, including inflammatory conditions and certain cancers. Inhibitors targeting cathepsin C are under clinical investigation for inflammatory conditions.
Inhibition of Cathepsin C enzymatic activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cathepsin C (CTSC).